Subscribe to Email Alerts
Menu
About Us
About INOVIQ
Market Opportunity
Board
The Team
Partners
Distributors
Compliance
Careers
Technology
Our Science
NETs Platform
SubB2M Platform
BARD1 Biomarker Technology
hTERT ICC Assay
Intellectual Property
Publications
Resources
Business Development
Products
Our Products
EXO-NET® Pan-Exosome
Product Overview
Technical Information
Data & Figures
Ordering
hTERT ICC Test
Pipeline
Development Pipeline
SubB2M CA15-3
SubB2M CA125
Exo-Ovarian Cancer Test
Exosome Therapeutics
Investors
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
INOVIQ Fact Sheet
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
News & Events
INOVIQ in the News
Conferences & Events
Contact
Contact Us
Subscribe to Email Alerts
INOVIQ in the News
Heading &
Sub-heading can be edited through HQI
News & Events
>
INOVIQ in the News
INOVIQ in the News
Conferences & Events
INOVIQ in the News
Filter by Year:
2024
2023
2022
2021
2020
2018
2017
29-Jul-2022
INOVIQ (ASX:IIQ) discusses US milestones
26-Jul-2022
INOVIQ study validates the use of SubB2M as an aid in diagnosing malignant melanoma
26-Jul-2022
Energy, miners and BNPL shares lead the way: Aus shares close 0.3% higher
26-Jul-2022
ASX in a holding pattern: Aus shares 0.2% higher at noon
22-Jul-2022
INOVIQ expands US footprint with new sales team
1-Jul-2022
Energy and miners drag ASX lower, down 0.6% over the week
1-Jul-2022
INOVIQ (ASX:IIQ) granted SubB2M US patent for diagnostic applications
22-Apr-2022
Inoviq expands collaboration with UQ to develop exosome-based ovarian cancer screening test
5-Apr-2022
INOVIQ wants to beat cancer to the punch with world-first diagnostic solutions
Previous
1
2
